您的電腦未安裝flash播放器,您可至至右列網址下載: http://get.adobe.com/tw/flashplayer/
Listed Companies > Listed Companies Info. > General Stock Board Listed Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
4154 Kino
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Ting Yen Hock Chong Ka Wee Chong Ka Wee 65-6281-3888 178 Paya Lebar Road,#04-02Singapore 409030 2011/12/28
Agent for litigious
and non-litigious matters
Tel of
Agent for litigious
and non-litigious matters
Address of
Agent for litigious
and non-litigious matters
Wang Fei-Ju 02-7734-5790 7F.-1, No.270, Sec. 4, Zhongxiao E. Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C.)
Industry Main Business
Biotechnology and Medical Care
Kino Biotech is a leading integrated bio-nutraceutical and cosmeceutical company specialized in product conceptualization, development, commercialization, brand marketing, sale and distribution of innovative healthcare and beauty products. Our core business is the sale of healthcare and beauty products under our own proprietary brands: Kinohimitsu, Activa and Xpertise. Kino Biotech is based in Singapore, the heart of Asia. We have over 4500 point of sales in China, Singapore, Malaysia, Vietnam, Thailand and Indonesia. The use of hybrid marketing including traditional media and new media has allowed for a holistic marketing strategy promoting our healthcare and beauty products to over 1.5 billion consumers. Collaboration with our key partners like Watsons, Guardian, Sasa, Tesco and Carrefour enables Kino Biotech to successfully bring its products to the mass market. Kino Biotech is constantly expanding our product lines and the reach of our products to new channels and new markets.
 
Market Information (2015/01/30)
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
19 23.55  23.50  23.50  -0.05  8 0.09 - -
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2015/02/01)
GTSM measures
adopted
(2015/02/01)
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.